<p>(<b>A</b>) iNOS protein is reduced in <i>Noc</i> KO MEFs following LPS treatment. WT and <i>Noc</i> KO MEFs treated with LPS for twenty-four hours were collected for protein extraction. Proteins were analyzed by Western blotting with α-iNOS antibody (a representative blot is shown in top panel) and protein levels were determined (normalized to β-tubulin levels) and plotted as mean (±SEM) of three independent MEF lines (bottom panel). (<b>B</b>) Expression of Nocturnin in <i>Noc</i> KO MEFs rescues the LPS induction of iNOS protein. <i>Noc</i> KO MEFs were electroporated with either empty FLAG vector (control) or a vector expressing a FLAG-Nocturnin fusion protein (NOC-FLAG). Forty-eight hours after electroporation, MEFs were treated for ...
<p>Tim-4 stably transfected cells RAW-pcDNA3-Tim-4 and control cells RAW-pcDNA3 were incubated with ...
<p>Primary cultured mouse BMDM was treated with or without 1 µg/ml LPS for 16 hrs. The protein expre...
Western blot quantitation of CD86 showed no significant difference with LPS or insulin administratio...
<p>Peritoneal Macrophages from WT and <i>Txnip<sup>−/−</sup></i> mice on the C57BL/6 background were...
<p>(A) 1400W (10 mg/kg body weight) was used to treat mice at 1 h prior to LPS (10 mg/kg body weight...
<p>(<b>A</b>) Putative NF-κB enhancer sites located in conserved regions in the <i>Nocturnin</i> gen...
<p>(<b>A</b>) Comparison of murine iNOS (<i>Nos2</i>) transcript levels in BM-MDSCs and spleen cells...
<p>MEFs treated with LPS for the indicated times were collected for total RNA isolation. mRNA levels...
<p>BV-2 cells were left untreated or incubated with 100 ng/ml wild type (WT), G2A, two different pre...
<p>A, B. RAW264.7 cells (A) or peritoneal macrophages (B) were treated with LPS (100 ng/ml) together...
<p>Cells (1×10<sup>6</sup>) were stimulated with 1 µg/mL LPS for the indicated periods of time (A an...
<p>(<b>A</b>) BV-2 cells were cultured in a 24-well plate at 5×10<sup>4</sup> cells/well and were ex...
<p>(A) Upper: PES pretreatment (30 min) inhibited iNOS expression in LPS (2 µg/mL)-stimulated cells ...
<p>Primary cultured mouse BMDM was treated with or without 1 µg/ml LPS for various time points from ...
<p>J774A.1 cells were treated with IS (1000–62.5 µM) for 1 h and then co-exposed to LPS (1 µg/ml) fo...
<p>Tim-4 stably transfected cells RAW-pcDNA3-Tim-4 and control cells RAW-pcDNA3 were incubated with ...
<p>Primary cultured mouse BMDM was treated with or without 1 µg/ml LPS for 16 hrs. The protein expre...
Western blot quantitation of CD86 showed no significant difference with LPS or insulin administratio...
<p>Peritoneal Macrophages from WT and <i>Txnip<sup>−/−</sup></i> mice on the C57BL/6 background were...
<p>(A) 1400W (10 mg/kg body weight) was used to treat mice at 1 h prior to LPS (10 mg/kg body weight...
<p>(<b>A</b>) Putative NF-κB enhancer sites located in conserved regions in the <i>Nocturnin</i> gen...
<p>(<b>A</b>) Comparison of murine iNOS (<i>Nos2</i>) transcript levels in BM-MDSCs and spleen cells...
<p>MEFs treated with LPS for the indicated times were collected for total RNA isolation. mRNA levels...
<p>BV-2 cells were left untreated or incubated with 100 ng/ml wild type (WT), G2A, two different pre...
<p>A, B. RAW264.7 cells (A) or peritoneal macrophages (B) were treated with LPS (100 ng/ml) together...
<p>Cells (1×10<sup>6</sup>) were stimulated with 1 µg/mL LPS for the indicated periods of time (A an...
<p>(<b>A</b>) BV-2 cells were cultured in a 24-well plate at 5×10<sup>4</sup> cells/well and were ex...
<p>(A) Upper: PES pretreatment (30 min) inhibited iNOS expression in LPS (2 µg/mL)-stimulated cells ...
<p>Primary cultured mouse BMDM was treated with or without 1 µg/ml LPS for various time points from ...
<p>J774A.1 cells were treated with IS (1000–62.5 µM) for 1 h and then co-exposed to LPS (1 µg/ml) fo...
<p>Tim-4 stably transfected cells RAW-pcDNA3-Tim-4 and control cells RAW-pcDNA3 were incubated with ...
<p>Primary cultured mouse BMDM was treated with or without 1 µg/ml LPS for 16 hrs. The protein expre...
Western blot quantitation of CD86 showed no significant difference with LPS or insulin administratio...